Chimerix’s (CMRX) “Hold” Rating Reiterated at Jefferies Financial Group
Jefferies Financial Group reissued their hold rating on shares of Chimerix (NASDAQ:CMRX – Free Report) in a research note published on Wednesday,Benzinga reports. The brokerage currently has a $8.50 price objective on the biopharmaceutical company’s stock, down from their prior price objective of $10.00. Several other equities analysts have also weighed in on CMRX. Wedbush […]
Jefferies Financial Group reissued their hold rating on shares of Chimerix (NASDAQ:CMRX – Free Report) in a research note published on Wednesday,Benzinga reports. The brokerage currently has a $8.50 price objective on the biopharmaceutical company’s stock, down from their prior price objective of $10.00. Several other equities analysts have also weighed in on CMRX. Wedbush […]
